Deregulating the Finnish OTC-drug market- a cost-benefit analysis
This study is an ex-ante cost-benefit analysis of a deregulation of OTC-drugs in Finland allowing over-the-counter pharmaceuticals to be sold outside pharmacies. It assumes a segmented market with differing consumer preferences over pharmacy and non-pharmacy services when purchasing OTC-pharmaceuticals. The results suggest that consumers have a lot to gain by the deregulation through a new lower-p
